Determinant of 30-Day Mortality of Pulmonary Legionellosis: Do Coinfections Matter?

Legionella cancer coinfections mortality outcomes pneumonia

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 07 08 2024
accepted: 10 09 2024
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: epublish

Résumé

We retrospectively reviewed 64 cases of cancer with pulmonary legionellosis (

Identifiants

pubmed: 39319087
doi: 10.1093/ofid/ofae529
pii: ofae529
pmc: PMC11420677
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofae529

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. D. P. K. reports honoraria and research support from Gilead Sciences and Astellas Pharma. He also received consultant fees from Astellas Pharma, Merck, and Gilead Sciences and is a member of the Data Review Committee for Cidara Therapeutics, AbbVie, Scynexis, and the Mycoses Study Group. All other authors report no potential conflicts.

Auteurs

Takahiro Matsuo (T)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Sebastian Wurster (S)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Ying Jiang (Y)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jeffrey Tarrand (J)

Section of Clinical Microbiology and Virology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Scott E Evans (SE)

Department of Pulmonology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Dimitrios P Kontoyiannis (DP)

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Classifications MeSH